s'authentifier
version française rss feed
Fiche concise
Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure.
Lafeuillade A., Soriano V., Suzan-Monti M., Stevenson M., Izopet J., Stellbrink H.-J.
AIDS Research and Therapy 9, 1 (2012) 23 - http://www.hal.inserm.fr/inserm-00742300
 (22853692) 
Highlights from the 2012 International Symposium on HIV & Emerging Infectious Diseases (ISHEID): from cART management to the search of an HIV cure.
Alain Lafeuillade () 1, Vicente Soriano2, Marie Suzan-Monti3, 4, Mario Stevenson5, Jacques Izopet6, Hans-Jürgen Stellbrink7
1 :  Service des Maladies Infectieuses
Hopital Font Pre – CHI de Toulon
Unité d'Infectiologie - 1208 avenue Colonel Picot 83056 Toulon
France
2 :  Department of Infectious Diseases
Hospital Carlos III
Calle Sinesio Delgado 10, 28029 Madrid
Espagne
3 :  ORS PACA
Observatoire Régional de la Santé Provence Alpes Côte d'Azur
23, rue Stanislas Torrents 13006 Marseille
France
4 :  SE4S - Sciences économiques et sociales, systèmes de santé, sociétés
http://www.se4s-orspaca.org/presentation/se4s.php
INSERM : U912 – Institut de recherche pour le développement [IRD] – Université de la Méditerranée - Aix-Marseille II – ORS PACA
23 rue Stanislas Torrents 13006 Marseille
France
5 :  Miller School of Medicine
University of Miami
1600 N.W. 10th Avenue, Miami, Florida 33136
États-Unis
6 :  Laboratoire de Virologie [Purpan]
Hôpital Purpan - Institut Fédératif de Biologie (IFB) – CHU Toulouse
Pôle Biologie - 330, avenue de Grande-Bretagne - TSA 40031 - 31059 Toulouse cedex 9
France
7 :  ICH Study Center - Infektions Medizinisches Centrum Hamburg Study Center
Krankenhaus Hamburg
Grindelallee 35 20146 Hamburg
Allemagne
ABSTRACT: The 2012 International Symposium on HIV and Emerging Infectious Diseases (ISHEID) provided a forum for investigators to hear the latest research developments in the clinical management of HIV and HCV infections as well as HIV-1 reservoirs and cure research. Combined anti-retroviral therapy (c-ART) has had a profound impact on the disease prognosis of individuals living with HIV-1 infection. However, although these anti-retroviral regimens are able to reduce plasma viremia to below the limits of detection for sustained periods of time, there is a rapid recrudescence in plasma viremia if treatment is interrupted. Therefore, despite this potent anti-retroviral suppression, HIV-1 is able to persist within the infected individual. The main 2012 ISHEID theme was, hence "searching for an HIV cure". In this report we not only give details on this main topic of the 2012 ISHEID but also summarize what has been discussed in the areas of HIV epidemiology, access to care, antiretroviral therapy management and recent progress in the therapy of HCV infection in patients with HIV.
Sciences du Vivant/Médecine humaine et pathologie/Maladies infectieuses
Anglais
1742-6405

Articles dans des revues avec comité de lecture
10.1186/1742-6405-9-23
AIDS Research and Therapy
Publisher BioMed Central
ISSN 1742-6405 
internationale
01/08/2012
01/08/2012
9
1
23

HIV pandemic – HIV cure – HIV reservoirs – Antiretroviral therapy – HCV coinfection – Access to care – New anti- HCV drugs
Liste des fichiers attachés à ce document : 
PDF
1742-6405-9-23.pdf(315.2 KB)
ANNEX
1742-6405-9-23.xml(63.5 KB)
1742-6405-9-23-S1.PPTX(295.5 KB)